The multiple layers of non-genetic regulation of PTEN tumour suppressor activity

European Journal of Cancer

Volumn 50, Issue 1, 2014, Pages 216-225

  Correia, Nádia C ^a   Gírio, Ana ^a   Antunes, Inês ^a   Martins, Leila R ^a   Barata, João T ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Cancer; Epigenetic, transcriptional, post transcriptional and post translational regulation; Leukaemia; Non genetic inactivation; PI3K Akt PKB pathway; PTEN; Tumour suppressor

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNTRANSLATED RNA;

CANCER INHIBITION; CARCINOGENESIS; DISEASE ASSOCIATION; EPIGENETIC REPRESSION; GENE DELETION; GENETIC REGULATION; HUMAN; LEUKEMIA; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

CANCER; EPIGENETIC, TRANSCRIPTIONAL, POST-TRANSCRIPTIONAL AND POST-TRANSLATIONAL REGULATION; LEUKAEMIA; NON-GENETIC INACTIVATION; PI3K-AKT/PKB PATHWAY; PTEN; TUMOUR SUPPRESSOR;

ANIMALS; CELL LINE, TUMOR; EPIGENOMICS; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84891626466     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.08.017     Document Type: Review

References (112)

1. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, and S.I. Wang et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
2. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, and A.H. Ligon et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362
3. J.T. Barata, A. Silva, J.G. Brandao, L.M. Nadler, A.A. Cardoso, and V.A. Boussiotis Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells J Exp Med 200 2004 659 669
4. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: rationale and promise Cancer Cell 4 2003 257 262
5. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501
6. F. Vazquez, S. Matsuoka, W.R. Sellers, T. Yanagida, M. Ueda, and P.N. Devreotes Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane Proc Natl Acad Sci USA 103 2006 3633 3638
7. M. Rahdar, T. Inoue, T. Meyer, J. Zhang, F. Vazquez, and P.N. Devreotes A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN Proc Natl Acad Sci USA 106 2009 480 485
8. N.R. Leslie, H. Maccario, L. Spinelli, and L. Davidson The significance of PTEN's protein phosphatase activity Adv Enzyme Regul 49 2009 190 196
9. Y. Shi, B.E. Paluch, X. Wang, and X. Jiang PTEN at a glance J Cell Sci 125 2012 4687 4692
10. P. Tibarewal, G. Zilidis, L. Spinelli, N. Schurch, H. Maccario, and A. Gray et al. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity Sci Signal 5 2012 ra18
11. A. Alimonti, A. Carracedo, J.G. Clohessy, L.C. Trotman, C. Nardella, and A. Egia et al. Subtle variations in Pten dose determine cancer susceptibility Nat Genet 42 2010 454 458
12. N. Chalhoub, and S.J. Baker PTEN and the PI3-kinase pathway in cancer Annu Rev Pathol 4 2009 127 150
13. P.K. Vogt, S. Kang, M.A. Elsliger, and M. Gymnopoulos Cancer-specific mutations in phosphatidylinositol 3-kinase Trends Biochem Sci 32 2007 342 349
14. J.T. Barata The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival Adv Enzyme Regul 51 2010 37 49
15. T. Tamguney, and D. Stokoe New insights into PTEN J Cell Sci 120 2007 4071 4079
16. K. Hettinger, F. Vikhanskaya, M.K. Poh, M.K. Lee, I. de Belle, and J.T. Zhang et al. C-Jun promotes cellular survival by suppression of PTEN Cell Death Differ 14 2007 218 229
17. K.M. Vasudevan, S. Gurumurthy, and V.M. Rangnekar Suppression of PTEN expression by NF-kappa B prevents apoptosis Mol Cell Biol 24 2004 1007 1021
18. T. Palomero, M.L. Sulis, M. Cortina, P.J. Real, K. Barnes, and M. Ciofani et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia Nat Med 13 2007 1203 1210
19. A. Larson Gedman, Q. Chen, S. Kugel Desmoulin, Y. Ge, K. LaFiura, and C.L. Haska et al. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group Leukemia 23 2009 1417 1425
20. A. Silva, P.Y. Jotta, A.B. Silveira, D. Ribeiro, S.R. Brandalise, and J.A. Yunes et al. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2-and gamma-secretase inhibitors Haematologica 95 2010 674 678
21. V. Stambolic, D. MacPherson, D. Sas, Y. Lin, B. Snow, and Y. Jang et al. Regulation of PTEN transcription by p53 Mol Cell 8 2001 317 325
22. Y. Tang, and C. Eng P53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction Cancer Res 66 2006 6139 6148
23. T. Virolle, E.D. Adamson, V. Baron, D. Birle, D. Mercola, and T. Mustelin et al. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling Nat Cell Biol 3 2001 1124 1128
24. R.A. Moorehead, C.V. Hojilla, I. De Belle, G.A. Wood, J.E. Fata, and E.D. Adamson et al. Insulin-like growth factor-II regulates PTEN expression in the mammary gland J Biol Chem 278 2003 50422 50427
25. L. Patel, I. Pass, P. Coxon, C.P. Downes, S.A. Smith, and C.H. Macphee Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN Curr Biol 11 2001 764 768
26. Y.H. Shen, L. Zhang, Y. Gan, X. Wang, J. Wang, and S.A. LeMaire et al. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells J Biol Chem 281 2006 7727 7736
27. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
28. J.M. Garcia, J. Silva, C. Pena, V. Garcia, R. Rodriguez, and M.A. Cruz et al. Promoter methylation of the PTEN gene is a common molecular change in breast cancer Genes Chromosomes Cancer 41 2004 117 124
29. L. Wang, W.L. Wang, Y. Zhang, S.P. Guo, J. Zhang, and Q.L. Li Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma Hepatol Res 37 2007 389 396
30. F. Alvarez-Nunez, E. Bussaglia, D. Mauricio, J. Ybarra, M. Vilar, and E. Lerma et al. PTEN promoter methylation in sporadic thyroid carcinomas Thyroid 16 2006 17 23
31. J. Roman-Gomez, A. Jimenez-Velasco, J.A. Castillejo, X. Agirre, M. Barrios, and G. Navarro et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia Blood 104 2004 2492 2498
32. C. Montiel-Duarte, L. Cordeu, X. Agirre, J. Roman-Gomez, A. Jimenez-Velasco, and E.S. Jose-Eneriz et al. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation Leuk Res 32 2008 709 716
33. C. Nishioka, T. Ikezoe, J. Yang, K. Udaka, and A. Yokoyama Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins Blood Cancer J 1 2011 e48
34. J. Lu, H.W. Jeong, N. Kong, Y. Yang, J. Carroll, and H.R. Luo et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex PLoS One 4 2009 e5577
35. A. Yoshimi, S. Goyama, N. Watanabe-Okochi, Y. Yoshiki, Y. Nannya, and E. Nitta et al. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins Blood 117 2011 3617 3628
36. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
37. Y. Lou, X. Yang, F. Wang, Z. Cui, and Y. Huang MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein Int J Mol Med 26 2010 819 827
38. J.G. Zhang, J.J. Wang, F. Zhao, Q. Liu, K. Jiang, and G.H. Yang MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) Clin Chim Acta 411 2010 846 852
39. C. Darido, S.R. Georgy, T. Wilanowski, S. Dworkin, A. Auden, and Q. Zhao et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis Cancer Cell 20 2011 635 648
40. N. Dey, N. Ghosh-Choudhury, B.S. Kasinath, and G.G. Choudhury TGFbeta-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion PLoS One 7 2012 e42316
41. M. Kato, S. Putta, M. Wang, H. Yuan, L. Lanting, and I. Nair et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN Nat Cell Biol 11 2009 881 889
42. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, and J. Wang et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
43. J.T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, and S.H. Rouhanifard et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo Genes Dev 23 2009 1327 1337
44. B. Liu, X. Wu, C. Wang, Y. Liu, Q. Zhou, and K. Xu MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN Biochim Biophys Acta 1822 2012 1692 1704
45. M. Garofalo, C. Quintavalle, G. Romano, C.M. Croce, and G. Condorelli MiR221/222 in cancer: their role in tumor progression and response to therapy Curr Mol Med 12 2012 27 33
46. Z. Chun-Zhi, H. Lei, Z. An-Ling, F. Yan-Chao, Y. Xiao, and W. Guang-Xiu et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN BMC Cancer 10 2010 367
47. C. Wang, Z. Bian, D. Wei, and J.G. Zhang MiR-29b regulates migration of human breast cancer cells Mol Cell Biochem 352 2011 197 207
48. W. Shi, K. Gerster, N.M. Alajez, J. Tsang, L. Waldron, and M. Pintilie et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer Cancer Res 71 2011 2926 2937
49. L. Poliseno, L. Salmena, L. Riccardi, A. Fornari, M.S. Song, and R.M. Hobbs et al. Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation Sci Signal 3 2010 ra29
50. Z. Wu, B. He, J. He, and X. Mao Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer Prostate 73 2012 596 604
51. L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, and S. Goodson et al. A microRNA polycistron as a potential human oncogene Nature 435 2005 828 833
52. C. Xiao, L. Srinivasan, D.P. Calado, H.C. Patterson, B. Zhang, and J. Wang et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes Nat Immunol 9 2008 405 414
53. K.J. Mavrakis, A.L. Wolfe, E. Oricchio, T. Palomero, K. de Keersmaecker, and K. McJunkin et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia Nat Cell Biol 12 2010 372 379
54. E. Rao, C. Jiang, M. Ji, X. Huang, J. Iqbal, and G. Lenz et al. The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation Leukemia 26 2012 1064 1072
55. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
56. Y. Tay, L. Kats, L. Salmena, D. Weiss, S.M. Tan, and U. Ala et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs Cell 147 2011 344 357
57. P. Johnsson, A. Ackley, L. Vidarsdottir, W.O. Lui, M. Corcoran, and D. Grander et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells Nat Struct Mol Biol 20 2013 440 446
58. F.A. Karreth, Y. Tay, D. Perna, U. Ala, S.M. Tan, and A.G. Rust et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma Cell 147 2011 382 395
59. M.S. Song, L. Salmena, and P.P. Pandolfi The functions and regulation of the PTEN tumour suppressor Nat Rev Mol Cell Biol 13 2012 283 296
60. A. Silva, J.A. Yunes, B.A. Cardoso, L.R. Martins, P.Y. Jotta, and M. Abecasis et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability J Clin Invest 118 2008 3762 3774
61. L.R. Martins, P. Lucio, M.C. Silva, K.L. Anderes, P. Gameiro, and M.G. Silva et al. Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia Blood 116 2010 2724 2731
62. M. Shehata, S. Schnabl, D. Demirtas, M. Hilgarth, R. Hubmann, and E. Ponath et al. Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia Blood 116 2010 2513 2521
63. J.W. Cheong, J.I. Eom, H.Y. Maeng, S.T. Lee, J.S. Hahn, and Y.W. Ko et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome Br J Haematol 122 2003 454 456
64. F. Dida, Y. Li, A. Iwao, T. Deguchi, E. Azuma, and Y. Komada Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells Exp Hematol 36 2008 1343 1353
65. S.J. Miller, D.Y. Lou, D.C. Seldin, W.S. Lane, and B.G. Neel Direct identification of PTEN phosphorylation sites FEBS Lett 528 2002 145 153
66. J. Torres, and R. Pulido The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation J Biol Chem 276 2001 993 998
67. A.M. Al-Khouri, Y. Ma, S.H. Togo, S. Williams, and T. Mustelin Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta J Biol Chem 280 2005 35195 35202
68. H. Maccario, N.M. Perera, L. Davidson, C.P. Downes, and N.R. Leslie PTEN is destabilized by phosphorylation on Thr366 Biochem J 405 2007 439 444
69. E.K. Yim, G. Peng, H. Dai, R. Hu, K. Li, and Y. Lu et al. Rak functions as a tumor suppressor by regulating PTEN protein stability and function Cancer Cell 15 2009 304 314
70. F. Okahara, H. Ikawa, Y. Kanaho, and T. Maehama Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein J Biol Chem 279 2004 45300 45303
71. Z. Li, X. Dong, Z. Wang, W. Liu, N. Deng, and Y. Ding et al. Regulation of PTEN by Rho small GTPases Nat Cell Biol 7 2005 399 404
72. K. Vo, B. Amarasinghe, K. Washington, A. Gonzalez, J. Berlin, and T.P. Dang Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation Mol Cancer 10 2011 138
73. N.R. Leslie, and M. Foti Non-genomic loss of PTEN function in cancer: not in my genes Trends Pharmacol Sci 32 2011 131 140
74. F. Vazquez, S.R. Grossman, Y. Takahashi, M.V. Rokas, N. Nakamura, and W.R. Sellers Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex J Biol Chem 276 2001 48627 48630
75. J.S. Kim, J.I. Eom, J.W. Cheong, A.J. Choi, J.K. Lee, and W.I. Yang et al. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia Clin Cancer Res 13 2007 1019 1028
76. F. Okahara, K. Itoh, A. Nakagawara, M. Murakami, Y. Kanaho, and T. Maehama Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation Mol Biol Cell 17 2006 4888 4895
77. J.E. Fata, S. Debnath, E.C. Jenkins Jr., and M.V. Fournier Nongenomic mechanisms of PTEN regulation Int J Cell Biol 2012 2012 379685
78. L.C. Trotman, X. Wang, A. Alimonti, Z. Chen, J. Teruya-Feldstein, and H. Yang et al. Ubiquitination regulates PTEN nuclear import and tumor suppression Cell 128 2007 141 156
79. S.M. Planchon, K.A. Waite, and C. Eng The nuclear affairs of PTEN J Cell Sci 121 2008 249 253
80. W.H. Shen, A.S. Balajee, J. Wang, H. Wu, C. Eng, and P.P. Pandolfi et al. Essential role for nuclear PTEN in maintaining chromosomal integrity Cell 128 2007 157 170
81. A. Ciechanover Proteolysis: from the lysosome to ubiquitin and the proteasome Nat Rev Mol Cell Biol 6 2005 79 87
82. S. Maddika, S. Kavela, N. Rani, V.R. Palicharla, J.L. Pokorny, and J.N. Sarkaria et al. WWP2 is an E3 ubiquitin ligase for PTEN Nat Cell Biol 13 2011 728 733
83. F. Fouladkou, T. Landry, H. Kawabe, A. Neeb, C. Lu, and N. Brose et al. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization Proc Natl Acad Sci USA 105 2008 8585 8590
84. X. Wang, L.C. Trotman, T. Koppie, A. Alimonti, Z. Chen, and Z. Gao et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN Cell 128 2007 129 139
85. E. Asselin, G.B. Mills, and B.K. Tsang XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells Cancer Res 61 2001 1862 1868
86. C. Van Themsche, V. Leblanc, S. Parent, and E. Asselin X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization J Biol Chem 284 2009 20462 20466
87. M.S. Song, L. Salmena, A. Carracedo, A. Egia, F. Lo-Coco, and J. Teruya-Feldstein et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network Nature 455 2008 813 817
88. J. Huang, J. Yan, J. Zhang, S. Zhu, Y. Wang, and T. Shi et al. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane Nat Commun 3 2012 911
89. T.P. Szatrowski, and C.F. Nathan Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res 51 1991 794 798
90. K. Irani, Y. Xia, J.L. Zweier, S.J. Sollott, C.J. Der, and E.R. Fearon et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts Science 275 1997 1649 1652
91. D. Trachootham, J. Alexandre, and P. Huang Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8 2009 579 591
92. 2 J Biol Chem 277 2002 20336 20342
93. N.R. Leslie, D. Bennett, Y.E. Lindsay, H. Stewart, A. Gray, and C.P. Downes Redox regulation of PI 3-kinase signalling via inactivation of PTEN EMBO J 22 2003 5501 5510
94. 2 regulates the angiogenic phenotype via PTEN oxidation J Biol Chem 280 2005 16916 16924
95. J. Cao, J. Schulte, A. Knight, N.R. Leslie, A. Zagozdzon, and R. Bronson et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity EMBO J 28 2009 1505 1517
96. S.T. Hui, A.M. Andres, A.K. Miller, N.J. Spann, D.W. Potter, and N.M. Post et al. Txnip balances metabolic and growth signaling via PTEN disulfide reduction Proc Natl Acad Sci USA 105 2008 3921 3926
97. S. Das, J.E. Dixon, and W. Cho Membrane-binding and activation mechanism of PTEN Proc Natl Acad Sci USA 100 2003 7491 7496
98. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic Biol Med 11 1991 81 128
99. J.D. West, and L.J. Marnett Endogenous reactive intermediates as modulators of cell signaling and cell death Chem Res Toxicol 19 2006 173 194
100. P.A. Grimsrud, H. Xie, T.J. Griffin, and D.A. Bernlohr Oxidative stress and covalent modification of protein with bioactive aldehydes J Biol Chem 283 2008 21837 21841
101. T.M. Covey, K. Edes, G.S. Coombs, D.M. Virshup, and F.A. Fitzpatrick Alkylation of the tumor suppressor PTEN activates Akt and beta-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer PLoS One 5 2010 e13545
102. C.X. Yu, S. Li, and A.R. Whorton Redox regulation of PTEN by S-nitrosothiols Mol Pharmacol 68 2005 847 854
103. M. Arif, P. Senapati, J. Shandilya, and T.K. Kundu Protein lysine acetylation in cellular function and its role in cancer manifestation Biochim Biophys Acta 1799 2010 702 716
104. K. Okumura, M. Mendoza, R.M. Bachoo, R.A. DePinho, W.K. Cavenee, and F.B. Furnari PCAF modulates PTEN activity J Biol Chem 281 2006 26562 26568
105. J. Zuber, O.I. Tchernitsa, B. Hinzmann, A.C. Schmitz, M. Grips, and M. Hellriegel et al. A genome-wide survey of RAS transformation targets Nat Genet 24 2000 144 152
106. T. Ikenoue, K. Inoki, B. Zhao, and K.L. Guan PTEN acetylation modulates its interaction with PDZ domain Cancer Res 68 2008 6908 6912
107. X. Wu, K. Hepner, S. Castelino-Prabhu, D. Do, M.B. Kaye, and X.J. Yuan et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2 Proc Natl Acad Sci USA 97 2000 4233 4238
108. D.M. Huffman, W.E. Grizzle, M.M. Bamman, J.S. Kim, I.A. Eltoum, and A. Elgavish et al. SIRT1 is significantly elevated in mouse and human prostate cancer Cancer Res 67 2007 6612 6618
109. B. Heltweg, T. Gatbonton, A.D. Schuler, J. Posakony, H. Li, and S. Goehle et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes Cancer Res 66 2006 4368 4377
110. H. Ota, E. Tokunaga, K. Chang, M. Hikasa, K. Iijima, and M. Eto et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells Oncogene 25 2006 176 185
111. L. Li, L. Wang, Z. Wang, Y. Ho, T. McDonald, and T.L. Holyoake et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib Cancer Cell 21 2012 266 281
112. M.S. Song, A. Carracedo, L. Salmena, S.J. Song, A. Egia, and M. Malumbres et al. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner Cell 144 2011 187 199